Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Endo’s Par Opts For Authorized Generic As It Debuts Lubiprostone In US
Multiple ANDA Sponsors Waiting In The Wings
Jan 05 2021
•
By
Dean Rudge
Endo's Par has a settlement that put it years ahead of ANDA rivals. • Source: Shutterstock
More from Generics
More from Products